speaker-photo

Julia Chernova

Director, Biostatistics at Cytel, Digital Biomarkers Expert Stat (SME) | Digital Health for Sanofi

Quantitative data scientist with 10+ years experience in top-tier U.K. academia and international pharma and PhD in Health Data Science from Cambridge University.
Experience covers scientific and operational integration of data from wearables/sensors, RCT and observational trial designs, RWE, data analysis, MCMC, ML, Bayesian, project management and digital data product development in clinical drug development and medical affairs.
Bringing innovative solutions to support decision-making, leading cross-functional teams, gap analysis, stakeholder management and generating insights to tackle business challenges.

Julia Chernova

Director, Biostatistics at Cytel, Digital Biomarkers Expert Stat (SME) | Digital Health for Sanofi

Cytel

Linkedin Logo

 

14:20 - 15:00 PM

Friday 08th Nov

Innovation in Clinical Drug Development - Digital Measures Integration as a Coordination Challenge

Digital measures integration in clinical development is a part of clinical innovation and promises increased patient focus and cheaper drug development. However, the progress is slower than anticipated. I argue that one of the industry challenges is an internal and external coordination problem that should be solved to speed up clinical innovation.

Julia Chernova

Director, Biostatistics at Cytel, Digital Biomarkers Expert Stat (SME) | Digital Health for Sanofi

Cytel

Linkedin Logo